Font Size:
a
A
A
Keyword [Virological response]
Result: 41 - 57 | Page: 3 of 3
41.
Methylation Status Of The Stimulator Of Interferon Genes Promoter In Patients With Chronic Hepatitis B
42.
Correlations Between The Results At Different Periods Of Treatment In CHB
43.
Analysis Of Influencing Factors Of Virological Breakthrough And Virological Response In Patients With Chronic Hepatitis B
44.
Hepatitis B Virus Mutation Pattern RtA181S+T184I+M204I May Contribute To Multidrug Resistance In Clinical Practice:Analysis Of A Large Cohort Of Chinese Patients
45.
Clinical Study On Sofosbuvir And Velpatasvir In Treatment Of Chronic Hepatitis C
46.
Efficacy And Safety Analysis Of Different DAAs Regimens In The Treatment Of Patients With Genotype 1b Chronic Hepatitis C
47.
Study On Early Predictive Factors Of An Incomplete Viral Response With 48 Week-Entecavir Therapy In HBeAg-Positive Chronic Hepatitis B Patients
48.
A Long-term Clinical Study Of Virological And Hepatic Benefits Of Patients With Chronic Hepatitis C Virus Infected After DAA Treatment
49.
Analysis Of Risk Factors For Patients With Chronic HBV Infection To Obtain Complete Virological Response After Treatment With Nucleoside (t) Analogs And Progress To Hepatocellular Carcinoma
50.
A Retrospective Cohort Study Of Low Level Viremia And Progression Of Liver Hardness In Patients With Chronic Hepatitis B
51.
Clinical Sofosbuvir-based Therapies Achieved Satisfactory Virological Response In Chinese With Genotypes 3 And 6 Infection: A Real World Experience
52.
Follow-up Study Of Disease Progression In Patients With Chronic Hepatitis C Treated With Antiviral Therapy
53.
Serum Hepatitis B Virus RNA Levels Predict The Curative Effect In Chronic Hepatitis B Patients With High Viral Load Treated With Nucleos(t)ide Analogue
54.
Clinical Study On Sequential Treatment With Tenofovir Alafenamide For Chronic Hepatitis B Patients Treated With Entecavir
55.
Influencing Factors For The Partial Virological Response Of Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogs
56.
Evaluation Of The Long-term Efficacy Of DAA Drugs In Treating HCV Infected Individuals After Achieving SVR
57.
Correlation Between Hepatitis B Surface Antigen Kinetics And Clinical Prognosis Of Hepatitis B-related Diseases
<<First
<Prev
Next>
Last>>
Jump to